VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CINF
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CINFCincinnati Financial Corporation
$185.14$28.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCINFQuarterly Financials

Cincinnati Financial Corporation (CINF) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Cincinnati Financial Corporation (CINF) quarterly income statement — complete revenue, gross profit & net income history

CINF Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue2.86B3.08B3.73B3.25B2.57B2.54B3.32B2.54B2.94B3.36B1.81B2.6B2.24B3.11B1.41B820M1.22B3.32B1.78B2.29B
Revenue Growth %11.57%21.55%12.23%27.67%-12.57%-24.37%83.32%-2.34%30.97%7.77%28.44%217.68%83.99%-6.29%-21.01%-64.27%-45.31%23.35%-19.85%-15.44%
Medical Costs & Claims1.75B1.47B1.54B1.66B1.97B1.33B1.58B1.48B1.35B1.2B1.33B1.34B1.4B1.25B1.42B1.32B1.03B946M1.07B915M
Medical Cost Ratio %61.16%47.71%41.33%51.11%76.7%52.4%47.53%58.18%45.96%35.88%73.55%51.44%62.38%40.01%100.57%161.22%84.73%28.47%60.06%39.87%
Gross Profit1.11B1.61B2.19B1.59B598M1.21B1.74B1.06B1.59B2.15B479M1.26B843M1.87B-8M-502M186M2.38B713M1.38B
Gross Margin %38.84%52.29%58.67%48.89%23.3%47.6%52.47%41.82%54.04%64.12%26.45%48.56%37.62%59.99%-0.57%-61.22%15.27%71.53%39.94%60.13%
Gross Profit Growth %85.95%33.53%25.49%49.25%-62.3%-43.87%263.67%-15.89%88.14%15.2%6087.5%351.99%353.23%-21.41%-101.12%-136.38%-84.8%32.65%-34.23%-15.23%
Operating Expenses773M773M773M733M726M729M702M678M633M662M627M599M575M581M569M551M537M531M529M508M
OpEx / Revenue %27%25.06%20.75%22.57%28.29%28.72%21.14%26.65%21.57%19.73%34.62%22.99%25.66%18.66%40.35%67.2%44.09%15.98%29.64%22.14%
Depreciation & Amortization40M42M33M46M47M15M39M42M34M24M14M34M40M46M24M41M37M24M23M23M
Combined Ratio %88.16%72.77%62.08%73.68%104.99%81.13%68.67%84.83%67.53%55.6%108.17%74.43%88.04%58.67%140.92%228.41%128.82%44.45%89.69%62%
Operating Income339M840M1.41B855M-128M479M1.04B386M953M1.49B-148M666M268M1.29B-577M-1.05B-351M1.85B184M872M
Operating Margin %11.84%27.23%37.92%26.32%-4.99%18.87%31.33%15.17%32.47%44.4%-8.17%25.57%11.96%41.33%-40.92%-128.41%-28.82%55.55%10.31%38%
Operating Income Growth %364.84%75.37%35.87%121.5%-113.43%-67.85%802.7%-42.04%255.6%15.77%74.35%163.25%176.35%-30.28%-413.59%-220.76%-145.7%40.27%-70.03%-23.84%
EBITDA379M882M1.45B901M-81M494M1.08B428M987M1.51B-134M700M308M1.33B-553M-1.01B-314M1.87B207M895M
EBITDA Margin %13.24%28.59%38.81%27.74%-3.16%19.46%32.5%16.82%33.63%45.11%-7.4%26.87%13.74%42.81%-39.22%-123.41%-25.78%56.27%11.6%39%
Interest Expense13M34.7M13M14M13M13M13M14M13M14M13M13M14M13M14M13M13M14M13M13M
Non-Operating Income0-13M-13M-14M-13M-13M-13M-14M-13M-14M-13M-13M-14M-13M-14M-13M-13M-14M-13M-13M
Pretax Income326M840M1.41B855M-128M479M1.04B386M953M1.49B-148M666M268M1.29B-577M-1.05B-351M1.85B184M872M
Pretax Margin %11.39%27.23%37.92%26.32%-4.99%18.87%31.33%15.17%32.47%44.4%-8.17%25.57%11.96%41.33%-40.92%-128.41%-28.82%55.55%10.31%38%
Income Tax52M164M291M170M-38M74M220M74M198M307M-49M132M43M274M-161M-235M-85M376M31M169M
Effective Tax Rate %15.95%19.52%20.59%19.88%29.69%15.45%21.15%19.17%20.78%20.6%33.11%19.82%16.04%21.29%27.9%22.32%24.22%20.37%16.85%19.38%
Net Income274M676M1.12B685M-90M405M820M312M755M1.18B-99M534M225M1.01B-416M-818M-266M1.47B153M703M
Net Margin %9.57%21.91%30.11%21.09%-3.51%15.96%24.7%12.26%25.72%35.25%-5.47%20.5%10.04%32.53%-29.5%-99.76%-21.84%44.24%8.57%30.63%
Net Income Growth %404.44%66.91%36.83%119.55%-111.92%-65.77%928.28%-41.57%235.56%16.78%76.2%165.28%184.59%-31.09%-371.9%-216.36%-142.9%40.13%-68.39%-22.66%
EPS (Diluted)1.754.307.114.34-0.582.575.201.984.787.50-0.633.381.426.40-2.63-5.13-1.709.040.944.31
EPS Growth %401.72%67.32%36.73%119.19%-112.13%-65.73%925.4%-41.42%236.62%17.19%76.05%165.89%183.53%-29.2%-379.79%-219.03%-144.5%39.72%-68.56%-23.45%
EPS (Basic)1.774.197.184.38-0.582.595.252.004.827.54-0.633.401.436.45-2.63-5.13-1.709.140.954.36
Diluted Shares Outstanding156.57M157.75M157.8M157.8M156.4M157.7M157.7M157.5M157.9M157.8M156.9M158M158.5M158.2M158M159.6M160.4M162.5M162.9M162.9M